Intersect ENT's IPO

Intersect ENT raised a round of funding on July 24, 2014. Investors include Public.

Intersect ENT, formerly Sinexus, is a developer in local drug delivery focused on advancing clinically proven therapy solutions that improve quality of life for patients with ear, nose and throat cond…

Articles about Intersect ENT's IPO: